ATE52693T1 - Synergistische humaninterferonaktivitaet. - Google Patents

Synergistische humaninterferonaktivitaet.

Info

Publication number
ATE52693T1
ATE52693T1 AT83306443T AT83306443T ATE52693T1 AT E52693 T1 ATE52693 T1 AT E52693T1 AT 83306443 T AT83306443 T AT 83306443T AT 83306443 T AT83306443 T AT 83306443T AT E52693 T1 ATE52693 T1 AT E52693T1
Authority
AT
Austria
Prior art keywords
synergistic
human interferon
interferon activity
human
interferon
Prior art date
Application number
AT83306443T
Other languages
English (en)
Inventor
Christine W Czarniecki
Ernst H Rinderknecht
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE52693T1 publication Critical patent/ATE52693T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83306443T 1982-10-25 1983-10-24 Synergistische humaninterferonaktivitaet. ATE52693T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43675882A 1982-10-25 1982-10-25
EP83306443A EP0107498B1 (de) 1982-10-25 1983-10-24 Synergistische Humaninterferonaktivität

Publications (1)

Publication Number Publication Date
ATE52693T1 true ATE52693T1 (de) 1990-06-15

Family

ID=23733716

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83306443T ATE52693T1 (de) 1982-10-25 1983-10-24 Synergistische humaninterferonaktivitaet.

Country Status (6)

Country Link
EP (1) EP0107498B1 (de)
JP (1) JPH0653676B2 (de)
AT (1) ATE52693T1 (de)
AU (1) AU565205B2 (de)
CA (1) CA1339843C (de)
DE (1) DE3381553D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
IL71954A0 (en) * 1983-06-01 1984-09-30 Genentech Inc Gamma interferon-lymphotoxin synergism
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
DE3436637A1 (de) * 1984-10-05 1986-04-10 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US5190751A (en) * 1987-01-20 1993-03-02 Schering Corporation Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
DE3869789D1 (de) * 1987-01-20 1992-05-14 Schering Corp Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
EP0294160A1 (de) * 1987-06-02 1988-12-07 Schering Corporation Behandlung von chronischer Hepatitis B mit einer Mischung menschlicher rekombinanter Alpha- und Gamma-Interferone
US4973478A (en) * 1987-07-20 1990-11-27 Allelix Biopharmaceuticals, Inc. Treating inflammation with hepatocyte stimulating factor interferon β2
US6455051B1 (en) 1997-10-13 2002-09-24 Otsuka Pharmaceutical Co., Ltd. Ameliorant for hepatitis C therapeutic effect and application thereof
CU23432B6 (es) 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
JPS55154919A (en) * 1979-05-24 1980-12-02 Hayashibara Takeshi Preparation of interferon
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor

Also Published As

Publication number Publication date
DE3381553D1 (de) 1990-06-21
AU2055483A (en) 1984-05-03
EP0107498A3 (en) 1985-07-10
EP0107498B1 (de) 1990-05-16
JPS5998019A (ja) 1984-06-06
AU565205B2 (en) 1987-09-10
CA1339843C (en) 1998-04-28
EP0107498A2 (de) 1984-05-02
JPH0653676B2 (ja) 1994-07-20

Similar Documents

Publication Publication Date Title
ATE52693T1 (de) Synergistische humaninterferonaktivitaet.
FI843496A0 (fi) Anordning foer att finna tvaergaoende borrhaol i implantat i benmaergen.
FR2534803B1 (fr) Porte-empreinte dentaire et son utilisation
IT8348746A0 (it) Derivati amminometil-benzenici arilsostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni che li contengono
DE3365458D1 (en) Photopolymerizable compositions and their use
NZ187984A (en) N-3 5-dichlorophenyl-n'-2-chlorobenzoyl ureas and insecticidal composition
EP0133767A3 (en) Gamma interferon composition
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
DE3486111D1 (de) Menschliches gamma-interferonpolypeptidderivat.
FI890527A0 (fi) Synergistinen artropodisidaalinen koostumus
IT1169909B (it) Copolimero di dialliltereftalato e composizione che comprende detto copolimero
KR850000983A (de)
GB2138293B (en) Novel pesticidal compositions and their use
FI844897A7 (fi) Menetelmä humaanileukosyytin ja Gammainterferonin valmistamiseksi.
ZA849923B (en) Preservative and disinfectant compositions
EP0036036A3 (en) Vesicular film compositions and elements
ES273740Y (es) Conjunto de dispositivos y medios empleados en el ensartado de hebillas en cintas elasticas y otros.
ES288247Y (es) Suelo elastico perfeccionado.
IT1237088B (it) N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
IT8420082A0 (it) Agenti ad attivita'antibroncospastica e composizioni farmaceutiche che li contengono.
IT1178855B (it) Composti antibiotici utilizzabili per il trattamento di stati di neo plasia in uomini ed animali e composizioni farmaceutiche che li contengono
PH17426A (en) Benzoquinolizines possessing high presynapticadrenoceptor antagonistic activity and pharmaceutical compositions
IL68156A (en) N-(6-(n-methoxy-n-alkyl)amino-4-alkoxy-1,3,5-triazin-2-yl-aminocarbonyl)-benzenesulfonamides and herbicidal compositions containing them
IL66300A (en) Synergistic fungicidal compositions containing prochloraz and guazatine

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time